Atovaquone prophylaxis against Pneumocystis jirovecii pneumonia in immunosuppressed patients with autoimmune rheumatic diseases: Incidence and clinical characteristics of a breakthrough case–A retrospective cohort study

Journal of Infection and Chemotherapy · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles